Evidence map›Paper›PMID 22912575›Full record

ArticlePLoS pathogens2012

HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.

Frédéric Catez, Christel Picard, Kathrin Held, Sylvain Gross, Antoine Rousseau, Diethilde Theil, Nancy Sawtell, Marc Labetoulle, Patrick Lomonte

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Frédéric CatezVirus and Centromere team, Centre de Génétique et de Physiologie Moléculaire et Cellulaire CNRS, UMR5534, Villeurbanne, France.
Christel Picard
Kathrin Held
Sylvain Gross
Antoine Rousseau
Diethilde Theil
Nancy Sawtell
Marc Labetoulle
Patrick Lomonte
Université Claude Bernard Lyon 1 · FRLudwig-Maximilians-Universität München · DECentre National de la Recherche Scientifique · FRCincinnati Children's Hospital Medical Center · USLaboratoire de Virologie Moléculaire et Structurale · FRUniversité Paris-Sud · FR

Funding

HSV latency and reactivation and the novel neuronal regulation of VP16 in vivo.R01AI093614 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI SAWTELL, NANCY M. · 2012 to 2016
$2.5M
NIAID NIH HHS R01 AI093614
6 · The paper itself

Abstract

Major human pathologies are caused by nuclear replicative viruses establishing life-long latent infection in their host. During latency the genomes of these viruses are intimately interacting with the cell nucleus environment. A hallmark of herpes simplex virus type 1 (HSV-1) latency establishment is the shutdown of lytic genes expression and the concomitant induction of the latency associated (LAT) transcripts. Although the setting up and the maintenance of the latent genetic program is most likely dependent on a subtle interplay between viral and nuclear factors, this remains uninvestigated. Combining the use of in situ fluorescent-based approaches and high-resolution microscopic analysis, we show that HSV-1 genomes adopt specific nuclear patterns in sensory neurons of latently infected mice (28 days post-inoculation, d.p.i.). Latent HSV-1 genomes display two major patterns, called "Single" and "Multiple", which associate with centromeres, and with promyelocytic leukemia nuclear bodies (PML-NBs) as viral DNA-containing PML-NBs (DCP-NBs). 3D-image reconstruction of DCP-NBs shows that PML forms a shell around viral genomes and associated Daxx and ATRX, two PML partners within PML-NBs. During latency establishment (6 d.p.i.), infected mouse TGs display, at the level of the whole TG and in individual cells, a substantial increase of PML amount consistent with the interferon-mediated antiviral role of PML. "Single" and "Multiple" patterns are reminiscent of low and high-viral genome copy-containing neurons. We show that LAT expression is significantly favored within the "Multiple" pattern, which underlines a heterogeneity of LAT expression dependent on the viral genome copy number, pattern acquisition, and association with nuclear domains. Infection of PML-knockout mice demonstrates that PML/PML-NBs are involved in virus nuclear pattern acquisition, and negatively regulate the expression of the LAT. This study demonstrates that nuclear domains including PML-NBs and centromeres are functionally involved in the control of HSV-1 latency, and represent a key level of host/virus interaction.

Indexed as

AnimalsCarrier ProteinsCells, CulturedCentromereCo-Repressor ProteinsDNA HelicasesGene Expression Regulation, ViralGenetic LociGenome, ViralHerpes SimplexHerpesvirus 1, HumanHumansIntracellular Signaling Peptides and ProteinsMiceMice, Inbred BALB CMice, KnockoutAtrx protein, mouseCarrier ProteinsCo-Repressor ProteinsDaxx protein, mouseDNA HelicasesIntracellular Signaling Peptides and ProteinsMolecular ChaperonesNuclear ProteinsPml protein, mousePromyelocytic Leukemia ProteinTranscription FactorsTumor Suppressor ProteinsX-linked Nuclear Protein

Identifiers

PMID22912575
PMCPMC3415458
OpenAlexW2083360261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.